Literature DB >> 1522941

Astroglia in Alzheimer's disease.

R C Frederickson1.   

Abstract

Amyloid deposits are characteristic of Alzheimer's Disease (AD) and there is growing evidence that amyloid may play an important role in the genesis of this neurodegenerative disease. This review discusses data which suggests that reactive astrocytes and microglia may be a necessary concomitant with amyloid to produce the neuropathology which manifests as AD. Several hypotheses and supporting data for mechanisms by which reactive astrocytes may mediate this neuropathology are presented. These include the possibility that amyloid induces excitotoxicity by interferring with astrocytic glutamate uptake, the possibility that amyloid has this effect via an action on a tachykinin-related receptor and the possibility that proteoglycans released by astrocytes may facilitate the deposition of amyloid plaques. Both symptomatic treatment to enhance cognitive function and treatment to stop the progression of AD are needed. It is hoped that answers to some of the unique questions raised here may provide new insight into the etiology and treatment of AD.

Entities:  

Mesh:

Year:  1992        PMID: 1522941     DOI: 10.1016/0197-4580(92)90036-w

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  12 in total

Review 1.  P2 receptors and neuronal injury.

Authors:  Heike Franke; Ute Krügel; Peter Illes
Journal:  Pflugers Arch       Date:  2006-04-28       Impact factor: 3.657

Review 2.  Is ammonia a pathogenetic factor in Alzheimer's disease?

Authors:  N Seiler
Journal:  Neurochem Res       Date:  1993-03       Impact factor: 3.996

3.  Pathological alterations of the cerebral microvasculature in Alzheimer's disease and related dementing disorders.

Authors:  L Buée; P R Hof; C Bouras; A Delacourte; D P Perl; J H Morrison; H M Fillit
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

4.  Expression of small heat-shock protein hsp 27 in reactive gliosis in Alzheimer disease and other types of dementia.

Authors:  K Renkawek; G J Bosman; W W de Jong
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

5.  Amyloid beta peptide potentiates cytokine secretion by interleukin-1 beta-activated human astrocytoma cells.

Authors:  B D Gitter; L M Cox; R E Rydel; P C May
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-07       Impact factor: 11.205

6.  The effects of chronic imidazoline drug treatment on glial fibrillary acidic protein concentrations in rat brain.

Authors:  G Olmos; R Alemany; P V Escriba; J A García-Sevilla
Journal:  Br J Pharmacol       Date:  1994-04       Impact factor: 8.739

7.  Expression of alpha B-crystallin in Alzheimer's disease.

Authors:  K Renkawek; C E Voorter; G J Bosman; F P van Workum; W W de Jong
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

Review 8.  Endogenous ornithine in search for CNS functions and therapeutic applications.

Authors:  N Seiler; G Daune-Anglard
Journal:  Metab Brain Dis       Date:  1993-09       Impact factor: 3.584

9.  Lactacystin stimulates stellation of cultured rat cortical astrocytes.

Authors:  Qing-Guo Ren; Ying Yu; Deng-Ji Pan; Xiang Luo; Xue-Zhen Wang; Wei Wang
Journal:  Neurochem Res       Date:  2008-09-04       Impact factor: 3.996

10.  Effect of quinolinic acid on human astrocytes morphology and functions: implications in Alzheimer's disease.

Authors:  Ka Ka Ting; Bruce J Brew; Gilles J Guillemin
Journal:  J Neuroinflammation       Date:  2009-12-10       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.